| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Xeris Pharmaceuticals Inc (NASDAQ: XERS)
XERS Technical Analysis
5
| As on 9th Jun 2023 XERS STOCK Price closed @ 2.83 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.99 & Strong Buy for SHORT-TERM with Stoploss of 2.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XERSSTOCK Price
| Open | 2.97 | Change | Price | % |
| High | 2.97 | 1 Day | -0.12 | -4.07 |
| Low | 2.83 | 1 Week | 0.19 | 7.20 |
| Close | 2.83 | 1 Month | 0.62 | 28.05 |
| Volume | 704958 | 1 Year | 0.47 | 19.92 |
| 52 Week High 2.95 | 52 Week Low 1.03 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| XERS Daily Charts |
XERS Intraday Charts |
Whats New @ Bazaartrend |
XERS Free Analysis |
|
|
XERS Important Levels Intraday
| RESISTANCE | 3.10 |
| RESISTANCE | 3.01 |
| RESISTANCE | 2.96 |
| RESISTANCE | 2.91 |
| SUPPORT | 2.75 |
| SUPPORT | 2.70 |
| SUPPORT | 2.65 |
| SUPPORT | 2.56 |
XERS Forecast May 2024
| 4th UP Forecast | 4.39 |
| 3rd UP Forecast | 3.89 |
| 2nd UP Forecast | 3.58 |
| 1st UP Forecast | 3.27 |
| 1st DOWN Forecast | 2.39 |
| 2nd DOWN Forecast | 2.08 |
| 3rd DOWN Forecast | 1.77 |
| 4th DOWN Forecast | 1.27 |
XERS Weekly Forecast
| 4th UP Forecast | 4.45 |
| 3rd UP Forecast | 3.93 |
| 2nd UP Forecast | 3.61 |
| 1st UP Forecast | 3.29 |
| 1st DOWN Forecast | 2.37 |
| 2nd DOWN Forecast | 2.05 |
| 3rd DOWN Forecast | 1.73 |
| 4th DOWN Forecast | 1.21 |
XERS Forecast2024
| 4th UP Forecast | 7.07 |
| 3rd UP Forecast | 5.71 |
| 2nd UP Forecast | 4.87 |
| 1st UP Forecast | 4.03 |
| 1st DOWN Forecast | 1.63 |
| 2nd DOWN Forecast | 0.79 |
| 3rd DOWN Forecast | -0.05 |
| 4th DOWN Forecast | -1.41 |
Xeris Pharmaceuticals Inc ( NASDAQ USA Symbol : XERS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
XERS Business Profile
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. It markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for primary periodic paralysis. The company also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was founded in 2005 and is headquartered in Chicago, Illinois. Address: 180 North LaSalle Street, Chicago, IL, United States, 60601
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service